NCT07126457Not yet recruiting
A Randomized Controlled Study on the Improvement of Medical Experience for Patients With Radiation-induced Oropharyngeal Mucositis Based on the RIS System of the Internet of Things
Source: ClinicalTrials.gov · Last updated 17 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is a researcher-initiated, multi-center, prospective, two-arm interventional randomized controlled study across the country. It aims to explore whether an Internet of Things-based RIS system can enhance the medical experience of patients with radiation-induced oropharyngeal mucositis during the diagnosis and treatment process among head and neck cancer patients undergoing radiotherapy.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- First submitted
- 10 Aug 2025
- Start date
- 1 Sept 2025
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Diseases
- Head and neck cancer
- NCT number
- NCT07126457
What you commit to
- Study type: Interventional
- Planned participants: 110
- From 1 Sept 2025 to the primary completion date, 1 Sept 2026
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have other uncontrolled serious diseases, such as unstable heart diseases requiring treatment, poorly controlled diabetes (fasting blood sugar \> 1.5 times the upper limit of the normal value), mental disorders, and a severe history of allergies.
Who the study is looking for
- Voluntarily sign the informed consent form;
- Reached the age of 18 on the date of signing the informed consent form, and under the age of 65;
- Patients diagnosed with head and neck tumors and receiving radiotherapy as per the 2017 WHO standards and guidelines.
- According to the doctor's assessment, patients may experience radiation-induced oropharyngeal mucositis during radiotherapy.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nanfang Hospital, Southern Medical University Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
| Huizhou Central People's Hospital Coordinator of this site? Confirm its status | Huizhou | China | Unknown status |
| Jieyang People's Hospital Coordinator of this site? Confirm its status | Jieyang | China | Unknown status |
| Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou Coordinator of this site? Confirm its status | Meizhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.